Abstract:Objective: Analysis of single centre results and identification of prognostic factors of surgical combined modality treatment in pathological proven stage IIIA-N2 non-small cell lung cancer (NSCLC). Methods: Out of a total of 996 resections for NSCLC between 2000 and 2006, 92 patients with radiological response or stable disease after induction chemotherapy for pathologically proven ipsilateral positive lymph nodes (N2-disease) underwent surgical exploration with the aim of complete resection. Adenocarcinoma and squamous cell carcinomas were equally present (48% vs 43%). Median follow-up of surviving patients (n=36) was 51 (10-94) months. Results: Complete resection (i.e., tumour with free margins and negative highest mediastinal lymph nodes, R0) was achieved in 68% (n=63), resection was uncertain or incomplete in 24% (n=22), while surgery was explorative in 8% (n=7). Pneumonectomy was performed in 24%, (bi)lobectomy in 62%, and sleeve lobectomy in 13% of patients. In-hospital mortality was 2.3%. Overall need for ICU stay was 18% (30% after pneumonectomy). Median hospital stay was 10 days (6-157). Downstaging of mediastinal lymph nodes (ypN0-1) was found in 43% (n=40). Overall survival at 5 years (5YS) was 33% (n=92), and after complete resection 43% (n=63). Detection of multilevel compared to single level positive nodes at initial mediastinoscopy was related to lower 5YS (17% vs 39%; p<0.005), and this was identified as an independent prognostic factor in a multivariate analysis of the examined presurgical variables. We found a trend for a better 5YS in patients with mediastinal nodal downstaging compared to patients with persistent N2 disease (49% vs 27%; p=0.095). In the subgroup with persistent N2 disease, single level disease has a significantly better survival (37% vs 7% 5YS, p<0.005). Multivariate survival analysis of the examined surgical variables identified completeness of resection and classification of ypN category (ypN0-1 and ypN2-single level vs multilevel-ypN2 and ypN3) as independent prognostic factors. Conclusions: Surgery after induction chemotherapy for stage IIIA-N2 NSCLC can be performed with an acceptable mortality and morbidity. Baseline single level N2 disease is an independent prognostic factor for long-term survival. Patients with mediastinal downstaging, but also a subgroup of patients with single level persistent N2 disease, after induction therapy have a rewarding survival.

Completeness of Resection and Long-term Survival of Patients Undergoing Resection for Pathological T3 Non-small-cell Lung Cancer: An International Association for the Study of Lung Cancer Analysis

Completeness of Resection and Long-Term Survival of Patients Undergoing Resection for Pathologic T3 NSCLC: an International Association for the Study of Lung Cancer Analysis.

Oncologic Outcomes of Patients with Resected T3N0M0 Non-small Cell Lung Cancer

Patterns Of Failure And Overall Survival In Patients With Completely Resected T3 No M0 Non-Small Cell Lung Cancer

[Survival Analysis of Completely Resected Stage IIIB Non-Small Cell Lung Cancer].

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Clinical Analysis of Sixty-Four Patients with T1an2m0 Stage Non-Small Cell Lung Cancer Who Had Undergone Resection

[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].

Reconsidering the American Joint Committee on Cancer Eighth Edition TNM Staging Manual Classifications for T2b and T3 NSCLC

Analysis of survival after complete resection of stageⅢA-N2 non-small cell lung cancer

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Survival Analysis of Patients with Non-Small Cell Lung Cancer Who Underwent Surgical Resection Following 4 Lung Cancer Resection Guidelines.

Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival

T4 Extension Alone is More Predictive of Better Survival Than a Tumour Size > 7 Cm for Resected T4N0-1M0 Non-Small-cell Lung Cancer

Prognosis Factors of Pathological Stage I Non-Small Cell Lung Cancer

Treatment of Clinical T4 Stage Superior Sulcus Non-Small Cell Lung Cancer: a Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.

Factors associated with incomplete resection for large, locally invasive non-small cell lung cancer

Survival and Risk Factors of Surgically Treated Mediastinal Invasion T4 Non-Small Cell Lung Cancer

Survival Analysis of 220 Patients with Completely Resected Stage-Ii Non-Small Cell Lung Cancer

[Surgical Resection of T4 Category Lung Cancer]

Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion Data From 1,055 Cases of Cancers <= 3 cm